<DOC>
	<DOCNO>NCT01778101</DOCNO>
	<brief_summary>This study pilot study evaluate safety efficacy lansoprazole preterm infant gastroesophageal reflux document 24hr pH impedance monitoring</brief_summary>
	<brief_title>Lansoprazole Preterm Infants With Reflux</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<criteria>preterm infant document gastrointestinal reflux 24hr pH monitoring unstable vital sings congenital anomaly upper gastrointestinal tract incuding esophagus drug history H2 blocker last 1 week medication warfarin , carbamazepine , phenytoin , rifampin renal hepatic dysfunction inappropriate clinical condition judge researcher</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>4 Months</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>preterm infant</keyword>
	<keyword>reflux</keyword>
	<keyword>impedance</keyword>
	<keyword>pH</keyword>
	<keyword>monitoring</keyword>
	<keyword>lansoprazole</keyword>
</DOC>